Skip to main content

Publication

A phase Ib/IIa trial to evaluate the CCK2 receptor antagonist Z-360 in combination with gemcitabine in patients with advanced pancreatic cancer
Meyer, T.,Caplin, M. E.,Palmer, D. H.,Valle, J. W.,Larvin, M.,Waters, J. S.,Coxon, F.,Borbath, I.,Peeters, M.,Nagano, E.,Kato, H.
(2010)
A phase Ib/IIa trial to evaluate the CCK2 receptor antagonist Z-360 in combination with gemcitabine in patients with advanced pancreatic cancer in Eur J Cancer 10.1016/j.ejca.2009.11.004